Health

AI ยท 251 companies ยท 437 deals tracked
251 Companies
437 Deals Tracked
AI Sector

Health Companies

Qura Qura ๐Ÿ‡ฎ๐Ÿ‡น Linda AI Linda AI ๐Ÿ‡ฎ๐Ÿ‡ช Captain T Cell Captain T Cell ๐ŸŒ You(th) Health Tech You(th) Health Tech ๐ŸŒ House Rx House Rx ๐ŸŒ Flinn.ai Flinn.ai ๐Ÿ‡ฆ๐Ÿ‡น Valinor Valinor ๐Ÿ‡บ๐Ÿ‡ธ Allos AI Allos AI ๐ŸŒ Third Way Health Third Way Health ๐Ÿ‡บ๐Ÿ‡ธ Medikarma Medikarma ๐Ÿ‡ฏ๐Ÿ‡ต

Latest Deals in Health

$8.75M
Antiverse, a Cardiff-based biotech company, has raised ยฃ7 million in a Series A funding round led by Soulmates Ventures, with participation from several investors. This funding will help scale its AI-designed therapeutic antibody platform aimed at undruggable disease targets, particularly in cystic fibrosis research. Antiverse has partnered with the Cystic Fibrosis Foundation to develop novel antibodies targeting the CFTR protein, and aims to advance its internal drug pipeline and clinical testing by 2027.
Investors: Soulmates Ventures
Health Mar 4, 2026
$270M
Radnet, a U.S.-based provider of outpatient diagnostic imaging services, has acquired Paris-based radiology AI company Gleamer in a deal valued at up to โ‚ฌ230 million (approximately $270 million). This acquisition aims to integrate Gleamer into Radnet's DeepHealth digital health subsidiary, enhancing its clinical AI capabilities and establishing it as the largest provider of radiology clinical AI solutions globally.
Health Mar 4, 2026
$41M
Ease Health, an AI-native CRM, EHR, and RCM platform for behavioral health providers, has raised $41 million in Series A funding led by Andreessen Horowitz. This funding aims to develop the first AI-native operating system tailored for behavioral health.
Investors: Andreessen Horowitz
Health Mar 3, 2026
$27.4M
Keycare, a virtual care company built on Epic, has raised $27.4 million in a financing round led by HealthX Ventures, with participation from 8VC, LRVHealth, Bold Capital Partners, and Ikigai Venture Partners. This funding aims to expand its AI-powered virtual care platform for health systems, bringing its total capital raised to over $55 million.
Investors: HealthX Ventures, 8VC, LRVHealth, Bold Capital Partners, Ikigai Venture Partners
Health Mar 3, 2026
$1.62M
qura, a Bologna, Italy-based developer of an AI-driven preventative health platform, raised โ‚ฌ1.5 million in pre-seed funding. The round was led by United Ventures, with participation from Vento, Italian Angels for Growth, and several individual angel investors. The funds will be used to expand the medical, engineering, and operations teams and accelerate product development.
Investors: United Ventures, Vento, Italian Angels for Growth
Health Mar 3, 2026
$1.89M
Delphyr, an Amsterdam-based provider of an AI platform for medical professionals, raised โ‚ฌ1.75 million in funding. The round included participation from notable investors such as the founders of Hugging Face and Degiro. The company plans to use the funds to expand its operations and enhance development efforts.
Investors: founders of Hugging Face, Degiro
Health Mar 3, 2026
$8.75M
Antiverse, a biotech company based in Wales, has secured a $9.3 million (ยฃ7 million) Series A investment to support its AI-designed therapeutic antibody technology. The company aims to address the challenge of treating diseases with 'undruggable' molecular targets. The investment, led by Soulmates Ventures, will enable Antiverse to scale its generative antibody design platform and expand collaborations, including with the Cystic Fibrosis Foundation. The company has achieved a significant reduction in development time for therapeutic-grade antibodies to under four months.
Investors: Soulmates Ventures
Health Mar 3, 2026
$9.3M
UK-based Antiverse has raised $9.3 million in a Series A funding round led by Soulmates Ventures, with participation from Innovation Investment Capital, Domino Ventures, and existing investors. The funding aims to enhance Antiverse's AI-driven platform for developing therapeutic antibodies targeting complex disease proteins, addressing the challenge of 'undruggable' molecular targets. This brings the total capital raised to over $20 million, supporting collaborations and advancing lead candidates toward clinical studies.
Investors: Soulmates Ventures, Innovation Investment Capital, Domino Ventures
Health Mar 3, 2026
$9.3M
Antiverse, a Cardiff, Wales-based AI-driven techbio company, raised $9.3 million in Series A funding to address challenges in the biotech sector. The funding round was led by Soulmates Ventures, with participation from Innovation Investment Capital, Domino Ventures, and existing investors DBW, Kadmos Capital, and I&I Biotech Fund, bringing the total raised to over $20 million.
Investors: Soulmates Ventures, Innovation Investment Capital, Domino Ventures, DBW, Kadmos Capital, I&I Biotech Fund
Health Mar 3, 2026
$9.3M
Antiverse, an AI-driven techbio company focused on de novo antibody design, has secured $9.3 million in Series A financing to enhance the development of therapeutic antibodies for historically undruggable disease targets. The funding round was led by Soulmates Ventures, with participation from Innovation Investment Capital, Domino Ventures, and existing investors, totaling over $20 million raised since inception.
Investors: Soulmates Ventures, Innovation Investment Capital, Domino Ventures
Health Mar 3, 2026
$1.89M
Delphyr, a Netherlands-based AI platform for healthcare, has raised โ‚ฌ1.75 million from investors including the founders of Hugging Face and Degiro. The funding aims to reduce administrative burdens on clinicians, allowing them to focus on patient care. Founded in 2023, Delphyr consolidates patient data and provides instant access to clinical guidelines, optimizing workflows and automating tasks. Its ambient listening feature captures consultations and converts them into structured notes, enhancing efficiency while maintaining privacy and security.
Investors: founders of Hugging Face, Degiro
Health Mar 3, 2026
$9.3M
UK-based Antiverse has secured $9.3 million in a Series A funding round led by Soulmates Ventures, with participation from Innovation Investment Capital, Domino Ventures, and existing investors. This funding aims to enhance Antiverse's AI-designed therapeutic antibodies for hard-to-target diseases, addressing the challenge of drug discovery for undruggable molecular targets. The company has raised over $20 million in total and plans to scale its antibody discovery platform and advance its drug pipeline.
Investors: Soulmates Ventures, Innovation Investment Capital, Domino Ventures
Health Mar 3, 2026
$1.62M
Milan-based Qura, an AI-powered health platform, has raised โ‚ฌ1.5 million in a pre-seed round led by United Ventures, with participation from Vento and Italian Angels for Growth (IAG). The company addresses the gap in traditional healthcare systems that inadequately manage ongoing subclinical symptoms affecting quality of life. Qura offers an integrated care pathway with comprehensive testing, AI analysis, and personalized health plans. The funding will support hiring, marketing, and expansion into additional European markets.
Investors: United Ventures, Vento, Italian Angels for Growth (IAG)
Health Mar 3, 2026
$1.62M
Milan-based Qura, an AI-powered health platform, has secured โ‚ฌ1.5 million in a pre-seed funding round led by United Ventures, with participation from Vento and Italian Angels for Growth (IAG). Qura addresses the gap in managing persistent subclinical symptoms that traditional primary care overlooks. The funding will be used to expand hiring, enhance AI capabilities, and prepare for growth in European markets.
Investors: United Ventures, Vento, Italian Angels for Growth (IAG)
Health Mar 3, 2026
Medimaps: Strategic Merger With Radiobotics To Expand Musculoskeletal Imaging Portfolio
Health Mar 3, 2026
$11.88M
Oska Health has raised โ‚ฌ11 million in seed funding to enhance its continuous care model for high-risk, chronically ill patients. The funding round was led by Capricorn Partners and SwissHealth Ventures, with additional participation from Revent, Calm Storm, LBBW Venture Capital, BMH, Gohub Ventures, and Aurum Impact.
Investors: Capricorn Partners, SwissHealth Ventures, Revent, Calm Storm, LBBW Venture Capital, BMH, Gohub Ventures, Aurum Impact
Health Mar 3, 2026
$41M
New York-based Ease Health has raised $41 million in a Series A funding round led by Andreessen Horowitz to develop an AI-native operating system for behavioral health providers. The platform integrates admissions, clinical care, and billing into a single system, aiming to reduce administrative burdens and improve efficiency. The funding will enhance product development and expand the company's reach among larger enterprise providers.
Investors: Andreessen Horowitz
Health Mar 2, 2026
$41M
Ease Health, a New York City-based provider of an AI-native CRM, EHR, and RCM platform, raised $41 million in Series A funding led by Andreessen Horowitz. The company plans to use the funds to expand its product and engineering teams, accelerate AI-powered automation development, and support growth with enterprise behavioral health.
Investors: Andreessen Horowitz
Health Mar 2, 2026
$13M
Braincheck has raised $13 million in Series A financing to enhance its enterprise cognitive care infrastructure and develop AI-assisted clinical capabilities. The funding round was led by Next Coast Ventures, with participation from S3 Ventures and UPMC Enterprises.
Investors: Next Coast Ventures, S3 Ventures, UPMC Enterprises
Health Mar 2, 2026
$3.5M
Outpost Bio, a London-based developer of AI-driven microbiology models, raised $3.5 million in pre-seed funding. The round was co-led by Merantix Capital and Seedcamp, with participation from OpenSeed VC and Defined, along with family offices and angel investors. The funds will be used to advance the company's experimental and modeling infrastructure.
Investors: Merantix Capital, Seedcamp, OpenSeed VC, Defined
Health Mar 2, 2026